Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed, Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02952508
What this trial is testing

Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom

Who this might be right for
Waldenstrom MacroglobulinemiaMultiple MyelomaChronic Lymphocytic Leukemia+6 more
Cellectar Biosciences, Inc. 120
Testing effectiveness (Phase 2)Ended earlyNCT03288493
What this trial is testing

P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Poseida Therapeutics, Inc. 105
Testing effectiveness (Phase 2)Study completedNCT00918333
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+25 more
Mayo Clinic 124
Early research (Phase 1)Study completedNCT00002818
What this trial is testing

High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+1 more
Virginia Commonwealth University 15
Testing effectiveness (Phase 2)Looking for participantsNCT04776330
What this trial is testing

A Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease

Who this might be right for
Multiple MyelomaNeoplasm, Plasma CellMultiple Myeloma in Relapse
Chongqing Precision Biotech Co., Ltd 80
Early research (Phase 1)Ended earlyNCT04975399
What this trial is testing

Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 26
Early research (Phase 1)Study completedNCT00962507
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
City of Hope Medical Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT06668792
What this trial is testing

An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Biocad 100
Testing effectiveness (Phase 2)Looking for participantsNCT07477912
What this trial is testing

Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma Refractory
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 30
Early research (Phase 1)Study completedNCT03263637
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies

Who this might be right for
Relapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more
AstraZeneca 44
Large-scale testing (Phase 3)Study completedNCT00633542
What this trial is testing

Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM)

Who this might be right for
Multiple Myeloma
Università Politecnica delle Marche 103
Testing effectiveness (Phase 2)UnknownNCT01754402
What this trial is testing

Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma

Who this might be right for
Multiple Myeloma
Cristina Gasparetto 56
Testing effectiveness (Phase 2)Study completedNCT00514137
What this trial is testing

Sunitinib in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Ended earlyNCT00538824
What this trial is testing

Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Weill Medical College of Cornell University 5
Testing effectiveness (Phase 2)UnknownNCT05055791
What this trial is testing

Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaLymphomaMultiple Myeloma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 312
Large-scale testing (Phase 3)UnknownNCT02916420
What this trial is testing

Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Jiangsu Simcere Pharmaceutical Co., Ltd. 73
Early research (Phase 1)Study completedNCT04163107
What this trial is testing

Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Norwegian University of Science and Technology 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07510100
What this trial is testing

Eque-cel for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Nanjing IASO Biotechnology Co., Ltd. 17
Large-scale testing (Phase 3)Study completedNCT00602511
What this trial is testing

Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma

Who this might be right for
Multiple Myeloma
Nordic Myeloma Study Group 300
Early research (Phase 1)Study completedNCT00003082
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Arizona 27
Next Page